Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2017 2
2018 3
2019 8
2020 9
2021 10
2022 6
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

32 results
Results by year
Filters applied: . Clear all
Page 1
Sleep Apnea-Specific Hypoxic Burden, Symptom Subtypes, and Risk of Cardiovascular Events and All-Cause Mortality.
Trzepizur W, Blanchard M, Ganem T, Balusson F, Feuilloy M, Girault JM, Meslier N, Oger E, Paris A, Pigeanne T, Racineux JL, Sabil A, Gervès-Pinquié C, Gagnadoux F. Trzepizur W, et al. Among authors: balusson f. Am J Respir Crit Care Med. 2022 Jan 1;205(1):108-117. doi: 10.1164/rccm.202105-1274OC. Am J Respir Crit Care Med. 2022. PMID: 34648724
Hypoxic burden and heart rate variability predict stroke incidence in sleep apnoea.
Blanchard M, Gervès-Pinquié C, Feuilloy M, Le Vaillant M, Trzepizur W, Meslier N, Goupil F, Pigeanne T, Balusson F, Oger E, Sabil A, Girault JM, Gagnadoux F; ERMES study group. Blanchard M, et al. Among authors: balusson f. Eur Respir J. 2021 Mar 25;57(3):2004022. doi: 10.1183/13993003.04022-2020. Print 2021 Mar. Eur Respir J. 2021. PMID: 33214210 Free article. No abstract available.
Patients with Metastatic Melanoma Receiving Anticancer Drugs: Changes in Overall Survival, 2010-2017.
Poizeau F, Kerbrat S, Happe A, Rault C, Drezen E, Balusson F, Tuppin P, Guillot B, Thuret A, Boussemart L, Dinulescu M, Pracht M, Lesimple T, Droitcourt C, Oger E, Dupuy A. Poizeau F, et al. Among authors: balusson f. J Invest Dermatol. 2021 Apr;141(4):830-839.e3. doi: 10.1016/j.jid.2020.07.038. Epub 2020 Oct 10. J Invest Dermatol. 2021. PMID: 33049268 Free article.
Hospitalization for adverse events under abiraterone or enzalutamide exposure in real-world setting: A French population-based study on prostate cancer patients.
Scailteux LM, Despas F, Balusson F, Campillo-Gimenez B, Mathieu R, Vincendeau S, Happe A, Nowak E, Kerbrat S, Oger E. Scailteux LM, et al. Among authors: balusson f. Br J Clin Pharmacol. 2022 Jan;88(1):336-346. doi: 10.1111/bcp.14972. Epub 2021 Jul 22. Br J Clin Pharmacol. 2022. PMID: 34224605 Free article.
Risk of cardiovascular disease following gonadotropin-releasing hormone agonists vs antagonists in prostate cancer: Real-world evidence from five databases.
George G, Garmo H, Scailteux LM, Balusson F, De Coster G, De Schutter H, Kuiper JG, Oger E, Verbeeck J, Van Hemelrijck M. George G, et al. Among authors: balusson f. Int J Cancer. 2021 May 1;148(9):2203-2211. doi: 10.1002/ijc.33397. Epub 2020 Nov 23. Int J Cancer. 2021. PMID: 33186481 Free PMC article.
32 results